Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles3 certified filings for “Regulatory Affairs Director” (Regulatory Affairs Managers) in MA: $241k–$257k, median $257k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
- 3 certified filings for “Regulatory Affairs Director” (Regulatory Affairs Managers) in MA: $241k–$257k, median $257k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
This is what you will do:
The Patient Experience Team (PEX) fuels Alexion AstraZeneca Rare Disease ’s corporate priorities by ensuring the patient voice guides every stage of our work. Increasingly global regulators, and decision makers such as HTA bodies and payors recognize the value of lived patient experience data (PED) to inform therapeutic development regulatory decision-making in line with guidance including patient-focused drug development , while supporting coverage and access decisions that can impro ve real-world outcomes .
The Patient Experience and Regulatory Engagement role serves as a strategic bridge between Global Medical Affairs, R&D, Global Marketing & Market Access and the patient community . The role lead s the synthesis and application of PED , including patient preference studies, lived experience data and, patient reported outcome measures to ensure the patient perspective is integrated across the medical product lifecycle . The role provides strategic leadership for the incorporation of patient perspectives into regulatory interactions, including preparatory strategy for patient participation in key meetings where appropriate .
You will be responsible for :
• Leads cross functional strateg y with Development and Regulatory teams to advance the integration of patient experience data into regulatory submissions.
• T ranslat ing shifts and trends in the regulatory landscape that will inform patient experience data generation strategies and proper implementation including access expectations for HTAs and payor bodies
• Provides strategic leadership across cross-functional teams and patient community stakeholders to generate patient experience data ( PED)— including patient preference, patient-generated, and lived-experience evidence ultimately shaping patient ‑ informed risk/benefit narratives to support external stakeholder interactions.
• Lead strategic vendor partnerships on targeted initiatives, ensuring clear scope definition, effective stakeholder management, and timely delivery of high  quality outputs.
• Limited domestic and international travel (20-30%) with the ability to travel to meet with key stakeholders.
You will need to have:
• Bachelor’s degree: degree in data science or management preferred.
• 10 + years of experience in the Biotech/Pharmaceutical Industry or equivalent; preference for experience in Regulatory, Clinical Development , or Consulting .
• Experience developing innovative solutions and a bility to adapt quickly to disease ‑ area and team needs.
• Drive c hange by transforming traditional data ‑ use practices into leading ‑ edge, modern approaches working in partnership with colleagues.
• Demonstrated passion for patient and caregiver focused work .
• Demonstrated ability to influence senior leaders and drive strategic decisions across complex global matrix organizations
• An understanding of patient-focused drug development, experience generating or synthesizing patient experience data as part of regulatory submissions
• Demonstrated willingness and ability to leverage artificial intelligence and other emerging technologies to enhance efficiency, insight generation, and decision-making.
• Demonstrated ability to lead complex global initiatives, influence diverse stakeholder groups, and drive execution through matrix teams.
• The duties of this role are generally conducted in an office environment. As is typical of an office-based role, employees must be able, with or without an accommodation to: use a computer; engage in communications via phone, video, and
Apply on employer site ↗